Accès ouvert
2025
review
OpenAlex
Kai Chen, Mei Xue, Xianhua Meng, Guifang Li et autres
BACKGROUND: Precise prenatal diagnosis of Placenta accreta spectrum disorders (PAS) is challenging, and the diagnostic performance of conventional imaging modalities remains suboptimal. Artificial intelligence (AI) technologies have emerged as promising tools in assisting image analysis and improving diagnostic accuracy of PAS. Therefore, …
cn
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Wei Meng, Xianhua Meng, Hiroki Yamaguchi, Evelyn L. Sebastian et autres
us, de
(code pays fourni par la source)
Accès ouvert
2023
review
OpenAlex
Kai Chen, Xiaoxia Liu, Xianhua Meng, Hui Li et autres
Background: Despite some progress has been made in the pathogenesis and treatment of threatened miscarriage (TM), conventional treatment remains suboptimal. Thus, complementary medicine gradually become a new treatment option for treating threatened miscarriage. Gushen Antai Pills (GAP), a classic prescription of Traditional …
cn
(code pays fourni par la source)
2023
conference-abstract
OpenAlex
C. Han, Jessica L. Fleming, Amrendra Kumar, Cory D. Showalter et autres
Accès ouvert
2022
report
OpenAlex
kai Chen, Xiaoxia Liu, Xianhua Meng, Hui Li et autres
Review question / Objective: This meta-analysis aimed to systematically evaluate the therapeutic effects of integrating Gushen Antai Pills and dydrogesterone in the treatment of threatened miscarriage. Condition being studied: This meta-analysis was conducted to evaluate the efficacy and safety of integrated Gushen …
cn
(code pays fourni par la source)
Accès ouvert
2021
review
OpenAlex
Xianhua Meng, Kai Chen, Chenchen Yang, Hui Li et autres
Background: Enhanced recovery after surgery (ERAS) has been adopted in some maternity units and studied extensively in cesarean section (CS) in the last years, showing encouraging results in clinic practice. However, the present evidence assessing the effectiveness of ERAS for CS remains …
cn
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Arata Azuma, Digambar Behera, Melody P. Chung, Yasuhiro Kondoh et autres
BACKGROUND AND OBJECTIVE: In the SENSCIS trial in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD), nintedanib reduced the rate of decline in forced vital capacity (FVC) (mL/year) over 52 weeks by 44% in comparison with placebo, with manageable adverse events in …
jp, us, in, cn, ch, de
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Shengye Du, Yinghui Zhao, Changyu Lv, Meiling Wei et autres
Recently, we have been seeing emerging applications of non-invasive approaches using serum biomarkers including miRNA and proteins in detection of multiple cancers. Currently, majority of these methods only use solitary type of biomarkers, which often lead to non-satisfactory sensitivity and specificity in …
cn
(code pays fourni par la source)
2019
article
OpenAlex
Liu Xiao-xia, Xianhua Meng, Xiaohong Wang
Accès ouvert
2018
article
OpenAlex
Jun Ma, Ting Liu, Jie Jin, Jianda Hu et autres
AIM: Chinese adults with relapsed/refractory Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (Ph- ALL) have poor outcomes. PATIENTS & METHODS: We conducted a nationwide, retrospective, observational study to assess outcomes in this patient population. RESULTS: Of the 270 enrolled patients, 31% of …
cn, us
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Xianhua Meng, Yinghui Zhao, Jinyun Wang, Zheng Gao et autres
The present study aimed to examine the role and underlying mechanism of miRNA-758 (miR-758) expression in cancer tissues, blood and cervical exfoliated cells from patients with cervical cancer. A total of 49 patients with cervical cancer and 26 healthy people for cervical …
cn
(code pays fourni par la source)
2016
article
OpenAlex
Jun Ma, Ting Liu, Jie Jin, Jianda Hu et autres
Abstract Introduction: Outcomes are poor among Chinese adults with r/r ALL. Current recommendations in China for the treatment of adults with Ph- ALL include induction therapy with vincristine or vindesine, anthracyclines/anthraquinones, and corticosteroids; intensive consolidation therapy following complete remission (CR); and hematopoietic …
cn
(code pays fourni par la source)